Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2012 Apr;50(4):1480–1483. doi: 10.1128/JCM.06126-11

Molecular Diagnosis of Subcutaneous Pythium insidiosum Infection by Use of PCR Screening and DNA Sequencing

Stephen J Salipante a,b,, Daniel R Hoogestraat a, Dhruba J SenGupta a, Donald Murphey d, Kyriacos Panayides f, Emma Hamilton g, Irene Castañeda-Sánchez e, Jason Kennedy i, Peter W Monsaas a, Leonel Mendoza h, Karen Stephens a, James J Dunn e, Brad T Cookson a,c
PMCID: PMC3318510  PMID: 22205808

Abstract

Pythium insidiosum is an emerging human pathogen classified among brown algae and diatoms that can cause significant morbidity and mortality in otherwise healthy individuals. Here we describe a pediatric patient with pythiosis acquired in the southern United States, diagnosed by molecular screening and DNA sequencing of internal transcribed spacer region 1.

CASE REPORT

An otherwise healthy 14-year-old girl living in urban north Texas presented to an urgent care facility with a 2-week history of a progressively enlarging, erythematous bump on the medial aspect of her left lower leg. She denied recent travel but was noted to have gone swimming in a swimming pool with signs of algal overgrowth. She was treated with incision and drainage and given a course of oral cephalexin. Although initially responding to antibiotics, over 2 weeks she again developed worsening local edema and erythema. The patient was switched to oral clindamycin but did not show improvement, prompting hospital admission about 3 weeks into her illness. She was administered intravenous clindamycin, and an ultrasound of the area revealed soft-tissue swelling with some patchy areas suggestive of fluid accumulation but without clear signs of an abscess. Incision and drainage was performed, and a drain was placed. Wound cultures were sent and returned positive for Staphylococcus intermedius and Pseudomonas aeruginosa. Based on the culture sensitivities of those organisms, antibiotic therapy was tailored to cefepime, tobramycin, and clindamycin. The patient showed clinical improvement and was discharged on oral ciprofloxacin 1 week after admission.

After approximately 5 days, erythema and edema around the wound had visibly increased and the patient was readmitted approximately 1 month after onset of her initial symptoms. She was administered intravenous meropenem and amikacin and incision and drainage was repeated, revealing an abscess measuring 10 cm by 15 cm. A drain was again placed, and wound cultures were sent for growth of bacteria, fungi, and acid-fast bacilli. Histologic sections from debridement material demonstrated an acute and chronic inflammatory infiltrate, interrupted by eosinophilic pools comprised of poorly formed granulomas with central necrosis admixed with neutrophils, eosinophils, and mineralized debris (Fig. 1A). Rare hyphal elements on Gomori methenamine silver stain were identified (Fig. 1B and C). Consequently, amikacin was discontinued, and the patient was started on liposomal amphotericin B (250 mg intravenously [i.v.] once per day [QD]), with the addition of posaconazole (400 mg orally [p.o.] twice per day [BID]) after 4 days. Nevertheless, the patient continued to have worsening erythema, edema, and patchy flucutance at the wound site. Cultures of debridement material remained negative for fungal growth following 1 week of incubation, and one formalin-fixed paraffin-embedded (FFPE) tissue block was therefore submitted for molecular characterization to the University of Washington Molecular Diagnosis Microbiology Section. During this time the patient underwent another incision and drainage, and the abscess was found to have enlarged to approximately 12 cm by 15 cm. Intravenous antibiotics were continued, and a wound vacuum device was placed with thrice-weekly changes, and yet the lesion continued to slowly enlarge and to show progressive inflammation and tissue necrosis. Her worsening condition prompted more-extensive surgical debridement 1 week after the previous procedure. Histology revealed necrotizing and suppurative granulomas with additional abundant hyphal elements. Magnetic resonance imaging (MRI) demonstrated extensive inflammation along the subcutaneous tissue and muscle layers up to the level of the midthigh, with occlusion of the posterior tibial artery.

Fig 1.

Fig 1

Histological sections and pure culture of P. insidiosum. (A) Section of early debridement material stained using hematoxylin and eosin. Arrowheads indicate poorly formed granulomatous response. Original magnification, ×4. (B) Histology of early debridement material, with arrowheads indicating rare hyphal elements on Gomori methenamine silver stain. Original magnification, ×10. (C) Same preparation as described for panel B; 40× original magnification. (D) Histologic section demonstrating abundant organisms colonizing the surface of gangrenous tissue, visualized as described for panel B. (E) Sandwich preparation of cultured organism stained with lactophenol cotton blue; original magnification, ×100. Sparsely septate hyphae are observed, with no fruiting bodies. (F) Same preparation as described for panel E; original magnification, ×400.

DNA extraction from FFPE material was performed as reported previously (7). All PCR products were separated by electrophoresis using a 1% agarose gel and stained for visualization. PCR using primers directed against internal transcribed spacer (ITS) region 1 (primers ITS1 and ITS2) (14) yielded a product (Fig. 2A) that was subjected to bidirectional sequencing and contig assembly as described elsewhere (12). Results were submitted to a GenBank Basic Local Alignment Search Tool (BLAST) search. The top 25 matches from the BLAST search of this sequence (GenBank accession no. JQ305801) corresponded to various P. insidiosum isolates, with the highest-ranked match identical to the query sequence (GenBank accession no. 284073108 [100% identity, 100% query coverage, BLAST E value 1.78e-141, alignment length 276 bp]). Confirmatory sequencing was repeated on the FFPE tissue block and also performed on two additional FFPE blocks, by the use of primers flanking both ITS1 and COXI (cytochrome oxidase c subunit 1; primers OomCoxI-Levup and OomCoxI-Levlo [16]) regions. In all three blocks, amplification and sequencing of ITS1 resulted in contigs identical to that obtained from the initial block. COXI amplification was successful from only one of the three blocks (Fig. 2B), and a BLAST search of the resultant sequence (GenBank accession no. JQ305799) revealed significant homology to P. insidiosum (top 3 matches, representative GenBank accession no HQ708612.1 [99% identity, 97% query coverage, BLAST E value 0.0, alignment length 679 bp]).

Fig 2.

Fig 2

Molecular characterization of P. insidiosum. All panels were imaged on a 1% agarose gel alongside a 1-kb Plus ladder (Invitrogen). Panels represent PCR products from amplification of ITS1 (tissue block in duplicate) (A), COXI (all samples in duplicate) (B), full-length ITS (C), and 28s rRNA (D). T, FFPE tissue block; C, cultured organism; I, inhibition control (equal mixture of sample and positive amplification control); +, positive amplification control (Candida sorbosivorans DNA); −, negative control (no template).

Following molecular characterization, a pure culture of the infectious organism was subsequently obtained by placing unprocessed debridement material directly onto Sabourad's agar plates and incubating at 30°C (Fig. 1E and F). We conclude that standard processing of infected tissue (by mincing) is physically disruptive to the organism. DNA was extracted from samples of this culture by the use of an Ultraclean microbial DNA isolation kit (Mo-Bio) and submitted for molecular characterization using primers to amplify full-length ITS (ITS1 and ITS2 sequences) (14) (Fig. 2C), COXI (Fig. 2B), and 28s rRNA (14) (Fig. 2D) sequences. Sequences of both ITS1 and COXI identically matched those generated from tissue blocks. The top match for the 28s sequence data (GenBank accession no. JQ305800) was the corresponding sequence from P. insidiosum isolate CBS 574.85 (GenBank accession no. HQ665273.1 [99% identity, 99% query coverage, BLAST E value 0.0, alignment length 729 bp]), and the closest 22 matches for the full-length ITS sequence (GenBank accession no. JQ305801) were seen with P. insidiosum isolates (top match, GenBank accession no. AY151165.1 [99% identity, 100% query coverage, BLAST E value 0.0, alignment length 797 bp]).

Following initial molecular identification approximately 3.5 weeks after admission, a diagnosis of presumptive P. insidiosum soft-tissue infection was made and antimicrobial treatment was optimized against that agent (18, 19). Therapy was converted to micafungin (150 mg i.v. QD), terbinafine (500 mg p.o. QD), minocycline (100 mg p.o. BID), and posaconazole (200 mg p.o. QID). The patient underwent extensive circumferential debridement, revealing invasion of the tibial artery and vein. Limb salvage was next attempted by local debridement followed by potassium iodide-soaked gauze dressings for 1 week. Additionally, an investigational therapeutic P. insidiosum immunotherapy (23) was initiated 4 times weekly. Despite these interventions, extensive muscular necrosis with overlying eschars and worsening soft-tissue edema developed, prompting further debridement 5, 6, and 6.5 weeks after admission. Pathology specimens from those procedures demonstrated ongoing inflammation with poorly organized granulomas, eosinophils, worsening necrosis, arterial thrombosis, and additional abundant fungal septate and nonseptate hyphae. The highest concentration of organisms was observed colonizing the surface of gangrenous tissue (Fig. 1D).

Given the extensive involvement of the infection, and the generally poor prognosis of advanced pythiosis, the decision was made to perform an above-the-knee-amputation. Histological sections from the procedure showed deep extension of the infection into skeletal muscle, although the margins and popliteal lymph nodes were found to be clear of the organism. Following amputation, the patient showed immediate clinical improvement and her wound healed appropriately. The patient was discharged after 10 days of observation without antimicrobial therapy and remained free from signs of residual infection on follow-up.

Pythium insidiosum is a protist that inhabits bodies of fresh water in tropical, subtropical, and temperate climates (6, 11). It is a member of the oomycete (perosporomycetes) class, unusual organisms that show several morphological similarities to fungi: many are filamentous, sporulating organisms, marked by thick cell walls. Regardless, oomycetes are ecologically, genetically, and physiologically distinct from fungi. Phylogenetic analyses based on a variety of genetic loci have established that the lineage falls among the stramenopiles, which include brown algae and diatoms, representing an evolutionarily isolated branch of the eukaryotes (16, 17, 21). In biochemical support of this classification, oomycete cell walls are composed mostly of cellulose and polymerized beta-1,3-glucan, common for algae but dissimilar to the chitin (beta-1,4-N-acetylglucosamine) characteristic of true fungi (9). A number of oomycete species are known agents of disease in plants or in animals (including insects and fish), and yet P. insidiosum and recently recognized P. aphanidermatum (4) are the only members of the genus capable of infecting mammalian hosts (4, 13, 16).

Long recognized as a veterinary pathogen primarily affecting horses and canines (6), the first human cases of P. insidiosum infection were reported in 1985 (5, 10). Pythiosis (or “swamp cancer”) is now regarded as an emerging human disease. Less than 150 cases of human pythiosis have been reported to date, with the great majority occurring in Thailand, where the disease is considered endemic (10). Regardless, P. insidiosum has a wide geographic distribution, and there exist case studies of human pythiosis contracted from environmental sources across the globe, including rare cases in the United States (6, 15, 18). In the present case, the patient presumably acquired pythiosis from an artificial water reservoir in an urban setting (a neglected swimming pool with algal overgrowth).

If not recognized and treated early, pythiosis can rapidly progress to a life-threatening infection in otherwise healthy individuals (6, 15). The diagnosis was further complicated in this case by the initial presence of bacterial superinfection. In immunocompetent persons, infection with P. insidiosum typically affects vascular, ophthalmic, or subcutaneous tissues, but it may present as systemic disease in thalassemic or leukemic patients (22). Pythiosis can manifest with a variety of different symptoms depending on the site and severity of infection (6, 10). Vascular disease typically favors the arteries and may advance to cause thrombosis or aneurysm. Infection of the eye or subcutaneous tissues produces progressive granulomatous and ulcerating lesions. Given its unusual biology, the organism is resistant to antifungal and antimicrobial agents: radical surgery is a mainstay of treatment for pythiosis. Although particular drug cocktails or an experimental immunotherapy has been suggested to be of some benefit (1820, 23), in our patient medical management, including therapeutic immunotherapy (23), was unsuccessful.

There currently exists no “gold standard” method for the clinical diagnosis of P. insidiosum infection. Even isolating the organism in pure culture does not guarantee an accurate identification: the procedure is both time-consuming and technically challenging, and the organism may fail to generate characteristic zoospores when cultured in vitro (3, 6). Serological methods have been described, including complement fixation, immunodiffusion, fluorescent antibody tests, immunoblots, enzyme-linked immunosorbent assays (ELISA), and hemagglutinin tests (8). However, these techniques display variable sensitivity and specificity, especially during early infection when the immune response is not fully mounted (8). Definitive diagnosis can be achieved using molecular methods, including species-specific nested PCR (3) or DNA sequencing of variable regions (1, 2).

In general, sequence analysis of internal transcribed spacer (ITS) regions has proven to be a powerful tool for molecular diagnosis of fungal and parasitic pathogens (7, 12, 14). Situated between highly conserved rRNA structural genes, ITS sequences are present in all eukaryotes. These domains can be targeted for species-independent PCR amplification using “universal” primers directed against conserved sites in flanking rRNA sequences. Because they do not encode functional rRNAs or proteins, ITS sequences have diverged considerably among organisms: in many cases they harbor enough variability to allow discrimination between even closely related species (14). ITS1 (between the 18S and 5.8S rRNA genes), in particular, has been extensively validated for use in molecular identification. Given the morphological similarities between oomycetes and fungi, it is fortuitous that these primer binding sites remain highly conserved in P. insidiosum: as in this case, and as previously recognized (1, 2), standard molecular workup of a presumptive fungal pathogen can identify P. insidiosum. Here, we have demonstrated that ITS1 sequencing is robust enough to provide a definitive diagnosis even from small amounts of material that has been formalin fixed and paraffin embedded.

We additionally sequenced a separate variable locus, COXI, which previously proved useful in identifying Taenia solium infection (7). Studies examining COXI across oomycete species have suggested that sequencing ITS with COXI is synergistic, and in some cases COXI provides greater discriminative power among species than ITS alone (16). The suitability of COXI for clinical identification of oomycete infection has been proposed (16), and yet this is the first instance where it has been implemented in clinical practice. Nevertheless, probably due to the large size of the COXI amplicon, we found that it was more difficult to generate COXI PCR products from FFPE tissues than for ITS1. We were able to more sensitively detect the presence of P. insidiosum in a larger number of tissue blocks (all three) by the use of universal ITS1 primer sequences, whereas COXI amplified from only one block.

Because P. insidiosum is an emerging pathogen, it is anticipated that the frequency of infections with this agent will increase in the future. This case report illustrates that the diagnosis of pythiosis should be considered in any patient with suggestive exposure history and presumptive fungal forms by microscopy, especially if the infection is refractory to standard antifungals. The development of diagnostic tests for P. insidiosum remains an unsolved challenge; however, molecular identification can be performed within a clinically meaningful time frame and allows definitive diagnosis. We have found ITS1 to be a particularly robust target for molecular identification. More broadly, this report illustrates the value of molecular diagnosis in the context of an infectious agent that is unknown, difficult or impossible to culture, or unexpectedly recalcitrant to treatment or, as in this case study, exhibits all three properties simultaneously. PCR screening and DNA sequencing of variable regions, utilizing primer binding sites directed against highly conserved loci, provide a strategy to allow definitive identification of a range of pathogens, suspected or unsuspected (12), efficiently providing information that can inform patient care. A molecular screening approach is particularly helpful in instances where there is an extensive differential diagnosis or where pathogen-specific testing is suboptimal or unavailable (12).

Nucleotide sequence accession numbers.

The nucleotide sequences determined in this work are available under GenBank accession no. JQ305799, JQ305800, and JQ305801.

ACKNOWLEDGMENT

This work was supported by the Department of Laboratory Medicine, University of Washington Medical Center.

Footnotes

Published ahead of print 28 December 2011

REFERENCES

  • 1. Badenoch PR, et al. 2001. Pythium insidiosum keratitis confirmed by DNA sequence analysis. Br. J. Ophthalmol. 85:502–503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Bosco Sde M, et al. 2005. Human pythiosis, Brazil. Emerg. Infect. Dis. 11:715–718 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Botton SA, et al. 2011. Identification of Pythium insidiosum by nested PCR in cutaneous lesions of Brazilian horses and rabbits. Curr. Microbiol. 62:1225–1229 [DOI] [PubMed] [Google Scholar]
  • 4. Calvano TP, et al. 2011. Pythium aphanidermatum infection following combat trauma. J. Clin. Microbiol. 49:3710–3713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. De Cock AW, Mendoza L, Padhye AA, Ajello L, Kaufman L. 1987. Pythium insidiosum sp. nov., the etiologic agent of pythiosis. J. Clin. Microbiol. 25:344–349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Gaastra W, et al. 2010. Pythium insidiosum: an overview. Vet. Microbiol. 146:1–16 [DOI] [PubMed] [Google Scholar]
  • 7. Harrington AT, et al. 2009. Diagnosis of neurocysticercosis by detection of Taenia solium DNA using a global DNA screening platform. Clin. Infect. Dis. 48:86–90 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Jindayok T, Piromsontikorn S, Srimuang S, Khupulsup K, Krajaejun T. 2009. Hemagglutination test for rapid serodiagnosis of human pythiosis. Clin. Vaccine Immunol. 16:1047–1051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Kamoun S. 2003. Molecular genetics of pathogenic oomycetes. Eukaryot. Cell 2:191–199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Krajaejun T, et al. 2006. Clinical and epidemiological analyses of human pythiosis in Thailand. Clin. Infect. Dis. 43:569–576 [DOI] [PubMed] [Google Scholar]
  • 11. Mendoza L, Hernandez F, Ajello L. 1993. Life cycle of the human and animal oomycete pathogen Pythium insidiosum. J. Clin. Microbiol. 31:2967–2973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Murphy SC, et al. 2011. Molecular diagnosis of cystoisosporiasis using extended-range PCR screening. J. Mol. Diagn. 13:359–362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Pannanusorn S, et al. 2007. Random amplified polymorphic DNA typing and phylogeny of Pythium insidiosum clinical isolates in Thailand. Southeast Asian J. Trop. Med. Public Health 38:383–391 [PubMed] [Google Scholar]
  • 14. Rakeman JL, et al. 2005. Multilocus DNA sequence comparisons rapidly identify pathogenic molds. J. Clin. Microbiol. 43:3324–3333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Rinaldi MG, Seidenfeld SM, Fotherbill AM, McGough DA. 1989. Pythium insidiosum causes severe disease in healthy boy. Mycol. Obs. 9:7 [Google Scholar]
  • 16. Robideau GP, et al. 2011. DNA barcoding of oomycetes with cytochrome c oxidase subunit I and internal transcribed spacer. Mol. Ecol. Resour. 11:1002–1011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Schurko AM, et al. 2003. A molecular phylogeny of Pythium insidiosum. Mycol. Res. 107:537–544 [DOI] [PubMed] [Google Scholar]
  • 18. Shenep JL, et al. 1998. Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child. Clin. Infect. Dis. 27:1388–1393 [DOI] [PubMed] [Google Scholar]
  • 19. Sudjaritruk T, Sirisanthana V. 2011. Successful treatment of a child with vascular pythiosis. BMC Infect. Dis. 11:33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Thitithanyanont A, et al. 1998. Use of an immunotherapeutic vaccine to treat a life-threatening human arteritic infection caused by Pythium insidiosum. Clin. Infect. Dis. 27:1394–1400 [DOI] [PubMed] [Google Scholar]
  • 21. Van der Auwera G, et al. 1995. The phylogeny of the Hyphochytriomycota as deduced from ribosomal RNA sequences of Hyphochytrium catenoides. Mol. Biol. Evol. 12:671–678 [DOI] [PubMed] [Google Scholar]
  • 22. Vanittanakom N, et al. 2004. Identification of emerging human-pathogenic Pythium insidiosum by serological and molecular assay-based methods. J. Clin. Microbiol. 42:3970–3974 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Wanachiwanawin W, et al. 2004. Efficacy of immunotherapy using antigens of Pythium insidiosum in the treatment of vascular pythiosis in humans. Vaccine 22:3613–3621 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES